Bristol Myers therapy for schizophrenia safe in late-stage trial
hapabapa/iStock Editorial via Getty Images Bristol-Myers Squibb (New York Stock Exchange:BMY) announced Saturday that its experimental schizophrenia therapy KarXT, acquired ...
hapabapa/iStock Editorial via Getty Images Bristol-Myers Squibb (New York Stock Exchange:BMY) announced Saturday that its experimental schizophrenia therapy KarXT, acquired ...